Medical Device and Diagnostic Industry (MD+DI)

Dexcom CEO Talks G8 CGM Sensor

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
Business Wire

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes

LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
Nasdaq

DexCom (DXCM) Launches Latest CGM Sensor ONE in France

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...
Reuters

Dexcom launches over-the-counter continuous glucose sensors in the US

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. Stelo ...
FierceBiotech

Dexcom to resubmit G7 glucose monitor software for FDA review, pushing back US launch

Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its continuous glucose monitor, the G7, after the FDA raised questions about the device’s ...
Hosted on MSN

UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom’s Inc. (DXCM) ‘Buy’ Rating

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
Investing

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential

Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...